PTGS2 and Alzheimer disease: A study found that AChEIs not only increase brain ACh levels, but can also reduce the inflammatory response which plays a pivotal role in AD by lowering the secretion of pro-inflammatory molecules like PGE2 and TXB2 and the expression of both enzymes COX-1 and COX-2.